At a glance
ClinicalIndex Comparison RecordN/ACompleted· 156 enrolled
Drug / intervention
Calprotectin testother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Revision Total
In Brief
An observational study evaluating Calprotectin test for Prosthetic Joint Infection. Completed, enrolled 156 participants across 2 sites.
Detailed Summary
The purpose of this study is to investigate whether there are quantifiable differences in the level of calprotectin in the synovial fluid that allow separation of different modes of joint implant failure (e.g. infected, aseptic loosening). A subset of primary TKA patients (with history of OA) will be included as a baseline.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProsthetic Joint Infection
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 2018
Enrollment StartOct 2018
Primary CompletionJan 2020
Study CompletionMar 2020
TodayJul 2026
First PostedOct 3, 2018
Enrollment StartOct 29, 2018
Primary CompletionJan 7, 2020
Study CompletionMar 4, 2020
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 7.7 years ago
Interventions
Calprotectin testother
Calprotectin will be measured both by ELISA and point of care test.